RESUMEN
Mycoplasma hyopneumoniae is an economically-devastating and geographically-widespread pathogen that colonises ciliated epithelium, and destroys mucociliary function. M. hyopneumoniae devotes ~5% of its reduced genome to encode members of the P97 and P102 adhesin families that are critical for colonising epithelial cilia, but mechanisms to impair mucociliary clearance and manipulate host immune response to induce a chronic infectious state have remained elusive. Here we identified two surface exposed M. hyopneumoniae proteases, a putative Xaa-Pro aminopeptidase (MHJ_0659; PepP) and a putative oligoendopeptidase F (MHJ_0522; PepF), using immunofluorescence microscopy and two orthogonal proteomic methodologies. MHJ_0659 and MHJ_0522 were purified as polyhistidine fusion proteins and shown, using a novel MALDI-TOF MS assay, to degrade four pro-inflammatory peptides that regulate lung homeostasis; bradykinin (BK), substance P (SP), neurokinin A (NKA) and neuropeptide Y (NPY). These findings provide insight into the mechanisms used by M. hyopneumoniae to influence ciliary beat frequency, impair mucociliary clearance, and initiate a chronic infectious disease state in swine, features that are a hallmark of disease caused by this pathogen.
Asunto(s)
Aminopeptidasas/metabolismo , Proteínas Bacterianas/metabolismo , Bradiquinina/química , Metaloendopeptidasas/metabolismo , Mycoplasma hyopneumoniae/enzimología , Neuroquinina A/química , Neuropéptido Y/química , Sustancia P/química , Adhesinas Bacterianas/metabolismo , Animales , Inmunidad Innata , Proteómica , Porcinos , Tripsina/químicaRESUMEN
A series of peptide NK2 receptor agonists was evaluated for affinity, potency, efficacy, and selectivity at human recombinant NK2 and NK1 receptors expressed in CHO cells to identify compounds with the greatest separation between NK2 and NK1 receptor agonist activity. Binding studies were performed using displacement of [125I]-NKA binding to NK2 receptors and displacement of [3H]-Septide binding to NK1 receptors expressed in CHO cells. Functional studies examining the increase in intracellular calcium levels and cyclic AMP stimulation were performed using the same cell lines. A correlation was demonstrated between binding affinities (Ki) and potency to increase intracellular calcium (EC50) for NK2 and NK1 receptors. Ranking compounds by their relative affinity (Ki) or potency (EC50) at NK2 or NK1 receptors indicated that the most selective NK2 agonists tested were [Lys5,MeLeu9,Nle10]-NKA(4-10) (NK1/NK2 Ki ratio = 674; NK1/NK2 EC50 ratio = 105) and [Arg5,MeLeu9,Nle10]-NKA(4-10) (NK1/NK2 Ki ratio = 561; NK1/NK2 EC50 ratio = 70). The endogenous peptide, NKA, lacked selectivity with an NK1/NK2 Ki ratio = 20 and NK1/NK2 EC50 ratio = 1. Of the compounds selected for evaluation in cyclic AMP stimulation assays, [ß-Ala8]-NKA(4-10) had the greatest selectivity for activation of NK2 over NK1 receptors (NK1/NK2 EC50 ratio = 244), followed by [Lys5,MeLeu9,Nle10]-NKA(4-10) (ratio = 74), and NKA exhibited marginal selectivity (ratio = 2.8).
Asunto(s)
Neuroquinina A/análogos & derivados , Neuroquinina A/química , Receptores de Neuroquinina-1/química , Receptores de Neuroquinina-2/química , Proteínas Recombinantes/química , Animales , Células CHO , Calcio/metabolismo , Membrana Celular/metabolismo , Cricetinae , Cricetulus , AMP Cíclico/metabolismo , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Humanos , Péptidos/química , Reproducibilidad de los ResultadosRESUMEN
Tachykinin neurokinin 2 (NK2) receptor agonists may have potential to alleviate clinical conditions associated with bladder and gastrointestinal underactivity by stimulating contraction of visceral smooth muscle. The ability of [Lys5,MeLeu9,Nle10]-neurokinin A(4-10) (LMN-NKA) to elicit micturition and defecation was examined after repeated administration in groups of 2-10 conscious dogs. Administration of 10-100 µg/kg, i.v., four times daily for six consecutive days, reliably elicited micturition after ≥90% of doses and defecation after ≥50% of doses. Voiding occurred <4 minutes after dosing and was short lasting (<10 minutes). LMN-NKA was well tolerated, with emesis after â¼25% of doses at 100 µg/kg, i.v. Hypotension was induced by 100 µg/kg, i.v., of LMN-NKA but not by lower doses. Administration of 30-300 µg/kg, s.c., twice daily for seven consecutive days, reliably elicited both urination and defecation after 88%-100% of doses, and was accompanied by a high rate of emesis (50%-100%). The onset of voiding was rapid (<7 minutes) but was more prolonged than after intravenous administration (30-60 minutes). Emesis induced by 30 or 300 µg/kg, s.c., of LMN-NKA was significantly reduced (from 58% to 8% and from 96% to 54%, respectively) by a 30-minute pretreatment with the neurokinin 1 (NK1) receptor antagonist, (2S,3S)-N-(2-methoxybenzyl)-2-phenylpiperidin-3-amine (CP-99,994; 1 mg/kg, s.c.). The ability of selective NK2 receptor agonists to elicit on-demand voiding could potentially address a major unmet need in people lacking voluntary control of micturition and/or defecation. LMN-NKA unexpectedly activated NK1 receptors at doses that stimulated voiding, causing emesis and hypotension that may limit the clinical utility of nonselective NK2 receptor agonists.
Asunto(s)
Defecación/efectos de los fármacos , Hipotensión/inducido químicamente , Fragmentos de Péptidos/farmacología , Receptores de Neuroquinina-1/metabolismo , Receptores de Neuroquinina-2/metabolismo , Micción/efectos de los fármacos , Vómitos/inducido químicamente , Animales , Estado de Conciencia , Perros , Neuroquinina A/química , Fragmentos de Péptidos/efectos adversos , Fragmentos de Péptidos/farmacocinética , Distribución TisularRESUMEN
Linking the intrinsic tertiary structures of biomolecules to their native geometries is a central prerequisite for making gas-phase studies directly relevant to biology. The isolation of molecules in the gas phase eliminates hydrophilic interactions with solvents, to some extent mimicking a hydrophobic environment. Intrinsic structures therefore may resemble native ones for peptides that in vivo reside in a hydrophobic environment (e.g., binding pockets of receptors). In this study, we investigate doubly protonated neurokinin A (NKA) using IR-UV double resonance cold ion spectroscopy and find only five conformers of this decapeptide in the gas phase. In contrast, NMR data show that in aqueous solutions, NKA exhibits high conformational heterogeneity, which reduces to a few well-defined structures in hydrophobic micelles. Do the gas-phase structures of NKA resemble these native structures? The IR spectra reported here allow the validation of future structural calculations that may answer this question.
Asunto(s)
Gases/química , Modelos Químicos , Neuroquinina A/química , Interacciones Hidrofóbicas e Hidrofílicas , Espectroscopía de Resonancia Magnética , Micelas , Unión Proteica , Espectrofotometría Infrarroja , Agua/químicaRESUMEN
Ligand-receptor binding kinetics (i.e. association and dissociation rates) are emerging as important parameters for drug efficacy in vivo. Awareness of the kinetic behavior of endogenous ligands is pivotal, as drugs often have to compete with those. The binding kinetics of neurokinin 1 (NK1) receptor antagonists have been widely investigated while binding kinetics of endogenous tachykinins have hardly been reported, if at all. Therefore, the aim of this research was to investigate the binding kinetics of endogenous tachykinins and derivatives thereof and their role in the activation of the NK1 receptor. We determined the binding kinetics of seven tachykinins targeting the NK1 receptor. Dissociation rate constants (koff) ranged from 0.026±0.0029min-1 (Sar9,Met(O2)11-SP) to 0.21±0.015min-1 (septide). Association rate constants (kon) were more diverse: substance P (SP) associated the fastest with a kon value of 0.24±0.046nM-1min-1 while neurokinin A (NKA) had the slowest association rate constant of 0.001±0.0002nM-1min-1. Kinetic binding parameters were highly correlated with potency and maximal response values determined in label-free impedance-based experiments on U-251 MG cells. Our research demonstrates large variations in binding kinetics of tachykinins which correlate to receptor activation. These findings provide new insights into the ligand-receptor interactions of tachykinins and underline the importance of measuring binding kinetics of both drug candidates and competing endogenous ligands.
Asunto(s)
Proteínas del Tejido Nervioso/metabolismo , Neuroglía/metabolismo , Neuroquinina A/metabolismo , Receptores de Neuroquinina-1/metabolismo , Sustancia P/metabolismo , Taquicininas/metabolismo , Algoritmos , Animales , Astrocitoma/metabolismo , Unión Competitiva , Células CHO , Línea Celular Tumoral , Cricetulus , Impedancia Eléctrica , Humanos , Cinética , Ligandos , Proteínas del Tejido Nervioso/agonistas , Proteínas del Tejido Nervioso/genética , Neuroquinina A/análogos & derivados , Neuroquinina A/química , Fragmentos de Péptidos/química , Fragmentos de Péptidos/metabolismo , Ácido Pirrolidona Carboxílico/análogos & derivados , Ácido Pirrolidona Carboxílico/química , Ácido Pirrolidona Carboxílico/metabolismo , Ensayo de Unión Radioligante , Receptores de Neuroquinina-1/agonistas , Receptores de Neuroquinina-1/genética , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Sustancia P/análogos & derivados , Sustancia P/química , Taquicininas/químicaRESUMEN
A potentiometric, spectroscopic (UV-visible, CD and EPR) and electrospray ionization mass spectrometric (ESI-MS) study of Cu(II) binding to the neurokinin A with point mutation (S5A) (ANKA), His-Lys-Thr-Asp-Ala(5)-Phe-Val-Gly-Leu-Met-NH2 and its N-acethyl derivative (Ac-ANKA), Ac-His-Lys-Thr-Asp-Ala(5)-Phe-Val-Gly-Leu-Met-NH2 were carried out. For the ANKA and Ac-ANKA the additional deprotonation was not observed. It suggests that for the tachykinin peptides with C-terminal sequence of neurokinin A for the additional deprotonation the presence of the serine residue is necessary. For the Cu(II)-ANKA 1:2 system at physiological pH 7.4 the CuH2L2 species is present with histamine-like 4N, 2×{NH2,NIm} coordination mode. With increasing pH the deprotonation and coordination of amide nitrogen atoms occur and the CuH-2L, CuH-3L complexes are formed. In pH range 4.5 - 9.5 the dimeric Cu2HL2, Cu2L2 and Cu2H-1L2 species in solution are also present. To elucidate the products of the copper(II)- catalyzed oxidation of the ANKA and Ac-ANKA, the liquid chromatography-mass spectrometry (LC-MS) method and Cu(II)/hydrogen peroxide as a model oxidizing system were employed. In the presence of hydrogen peroxide with 1:1 peptide-H2O2 molar ratio for both peptides the oxidation of the methionine residue to methionine sulfoxide was observed. For the Cu(II)-peptide-hydrogen peroxide in 1:2:2 molar ratio systems oxidations of the histidine residues to 2-oxo-histidines and methionine sulfoxide to methionine sulfone were detected.
Asunto(s)
Alanina/química , Complejos de Coordinación/química , Cobre/química , Neuroquinina A/química , Oligopéptidos/química , Mutación Puntual , Serina/química , Alanina/genética , Animales , Cromatografía Liquida , Histidina/química , Humanos , Peróxido de Hidrógeno/química , Cinética , Espectrometría de Masas , Metionina/análogos & derivados , Metionina/química , Neuroquinina A/síntesis química , Neuroquinina A/genética , Oligopéptidos/síntesis química , Oligopéptidos/genética , Oxidación-Reducción , Protones , Serina/genéticaRESUMEN
We present the implementation of a new molecular mechanics program designed for use in mobile platforms, the first specifically built for these devices. The software is designed to run on Android operating systems and is compatible with several modern tablet-PCs and smartphones available in the market. It includes molecular viewer/builder capabilities with integrated routines for geometry optimizations and Monte Carlo simulations. These functionalities allow it to work as a stand-alone tool. We discuss some particular development aspects, as well as the overall feasibility of using computational chemistry software packages in mobile platforms. Benchmark calculations show that through efficient implementation techniques even hand-held devices can be used to simulate midsized systems using force fields.
Asunto(s)
Aplicaciones Móviles , Simulación de Dinámica Molecular , Diseño de Software , Compuestos Bicíclicos Heterocíclicos con Puentes/química , Cafeína/química , Método de Montecarlo , Neuroquinina A/químicaRESUMEN
The classical tachykinins, substance P, neurokinin A and neurokinin B are predominantly found in the nervous system where they act as neurotransmitters and neuromodulators. Significantly reduced levels of these peptides were observed in neurodegenerative diseases and it may be suggested that this reduction may also result from the copper(II)-catalyzed oxidation. The studies of the interaction of copper(II) with neurokinin A and the copper(II)-catalyzed oxidation were performed. Copper(II) complexes of the neurokinin A (His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH(2)) and acetyl-neurokinin A (Ac-His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH(2)) were studied by potentiometric, UV-Vis (UV-visible), CD (circular dichroism) and EPR spectroscopic methods to determine the stoichiometry, stability constants and coordination modes in the complexes formed. The histidine residue in first position of the peptide chain of neurokinin A coordinates strongly to Cu(II) ion with histamine-like {NH(2), N(Im)} coordination mode. With increasing of pH, the formation of a dimeric complex Cu(2)H(2)L(2) was found but this dimeric species does not prevent the deprotonation and coordination of the amide nitrogens. In the Ac-neurokinin A case copper(II) coordination starts from the imidazole nitrogen of the His; afterwards three deprotonated amide nitrogens are progressively involved in copper coordination. To elucidate the products of the copper(II)-catalyzed oxidation of the neurokinin A and Ac-neurokinin A, liquid chromatography-mass spectrometry (LC-MS) method and Cu(II)/hydrogen peroxide as a model oxidizing system were employed. Oxidation target for both studied peptides is the histidine residue coordinated to the metal ions. Both peptides contain Met and His residues and are very susceptible on the copper(II)-catalyzed oxidation.
Asunto(s)
Cobre/química , Modelos Químicos , Neuroquinina A/química , Animales , Catálisis , Dicroismo Circular , Cobre/metabolismo , Espectroscopía de Resonancia por Spin del Electrón , Humanos , Peróxido de Hidrógeno/química , Peróxido de Hidrógeno/metabolismo , Concentración de Iones de Hidrógeno , Enfermedades Neurodegenerativas/metabolismo , Neuroquinina A/metabolismo , Oxidación-Reducción , Espectrofotometría UltravioletaRESUMEN
The neurokinin NK2 receptor is known to pre-exist in equilibrium between at least three states: resting-inactive, calcium-triggering, and cAMP-producing. Its endogeneous ligand, NKA, mainly induces the calcium response. Using a FRET-based assay, we have previously discovered an allosteric modulator of the NK2 receptor that has the unique ability to discriminate among the two signaling pathways: calcium-signaling is not affected while cAMP signaling is significantly decreased. A series of compounds have been prepared and studied in order to better understand the structural determinants of this allosteric functional switch of a GPCR. Most of them display the same allosteric profile, with smooth pharmacomodulation. One compound however exhibits significantly improved modulatory properties of NKA induced signaling when compared to the original modulator.
Asunto(s)
Regulación Alostérica , Neuroquinina A/química , Receptores de Neuroquinina-2/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Animales , Señalización del Calcio , AMP Cíclico , Transferencia Resonante de Energía de Fluorescencia , Humanos , Hidrocarburos Aromáticos/química , Hidrocarburos Aromáticos/farmacología , Ligandos , Neuroquinina A/metabolismo , Conformación Proteica/efectos de los fármacos , Receptores Acoplados a Proteínas G , Receptores de Neuroquinina-2/química , Receptores de Neuroquinina-2/metabolismoRESUMEN
The neurokinin-2 receptor is a member of the rhodopsin family of G-protein coupled receptors, which represents one of the most relevant target families in small-molecule drug design. NK-2 receptors have been implicated in playing a pathophysiological role in asthma. Activation of the NK-2 receptor by its endogenous peptide agonist, tachykinins, is associated with diverse biological responses like bronchoconstriction, vasodepression, and regulation of endocrine functions. Agonist binding to the receptor is a crucial event in initiating signaling, and therefore characterization of the structural features of the agonists can reveal the molecular basis of receptor activation and help in rational design of novel therapeutics. In this study a molecular model for the interaction of the primary ligand NKA with its G-protein coupled receptor neurokinin-2 receptor has been developed. A three-dimensional model for the NK-2 receptor has been generated by homology modeling using rhodopsin as a template. A knowledge based docking of the NMR derived bioactive conformation of NKA to the receptor has been performed utilizing the ligand binding data obtained from the photoaffinity labeling and site-directed mutagenesis studies. The molecular model for the NKA/NK-2 receptor complex thus obtained sheds light on the topographical features of the binding pocket of the receptor and provides atomic insight into the biochemical data currently available for the receptor. The results of the receptor modeling studies have been used to discuss the molecular determinants for NK-2 receptor selectivity.
Asunto(s)
Neuroquinina A/metabolismo , Receptores de Neuroquinina-2/agonistas , Receptores de Neuroquinina-2/metabolismo , Secuencia de Aminoácidos , Animales , Sitios de Unión , Bovinos , Humanos , Enlace de Hidrógeno , Modelos Moleculares , Neuroquinina A/química , Unión Proteica , Conformación Proteica , Receptores de Neuroquinina-2/química , Rodopsina/químicaRESUMEN
Neurokinin A stimulates physiological responses in the peripheral and central nervous systems upon interacting primarily with the tachykinin NK2 receptor (NK2R). In this study, the structure of NKA bound to the NK2R is characterised by use of fluorescence resonance energy transfer. Four fluorescent NKA analogues with Texas red introduced at amino acid positions 1, 4, 7 and 10 were prepared. When bound to a NK2R carrying enhanced green fluorescent protein at the N-terminus, all peptides reduce green fluorescent protein fluorescence from 10% to 50% due to energy transfer. The derived donor-acceptor distances are 46, 55, 59 and 69 A for the fluorophore linked to positions 1-10, respectively. The monotonic increase in distance clearly indicates that the peptide adopts an extended structure when bound to its receptor. The present data are used, in combination with rhodopsin structure, fluorescence studies, photoaffinity labelling and site-directed mutagenesis data to design a computer model of the NKA-NK2R complex. We propose that the N-terminus of NKA is exposed and accessible to the extracellular medium. Subsequent amino acids of the NKA peptide become progressively more buried residues up to approximately one-third of the transmembrane-spanning domain.
Asunto(s)
Membrana Celular/metabolismo , Sistema Nervioso/metabolismo , Neuroquinina A/metabolismo , Neuronas/metabolismo , Receptores de Neuroquinina-2/metabolismo , Sitios de Unión/fisiología , Unión Competitiva/fisiología , Línea Celular , Membrana Celular/ultraestructura , Transferencia Resonante de Energía de Fluorescencia , Proteínas Fluorescentes Verdes/metabolismo , Humanos , Sustancias Macromoleculares/química , Sustancias Macromoleculares/metabolismo , Modelos Moleculares , Estructura Molecular , Neuroquinina A/análogos & derivados , Neuroquinina A/química , Neuronas/ultraestructura , Péptidos/química , Péptidos/metabolismo , Estructura Terciaria de Proteína/fisiología , Receptores de Neuroquinina-2/agonistas , Receptores de Neuroquinina-2/química , XantenosRESUMEN
The conformational features of some glycine-monosubstituted analogues of neurokinins A and B were investigated by the method of theoretical conformational analysis. The calculated geometry and energy parameters permitted one to determine the structural role of each of these substituted amino acids in the mechanism of folding of the low-energy conformational states of neuropeptides. On the basis of the calculated data and the results of biological tests of these analogues, the structure-function relationships of neurokinins A and B were discussed.
Asunto(s)
Sustitución de Aminoácidos , Glicina/química , Modelos Moleculares , Neuroquinina A/química , Neuroquinina B/química , Sustitución de Aminoácidos/genética , Glicina/genética , Neuroquinina A/genética , Neuroquinina B/genética , Estructura Secundaria de Proteína/genéticaRESUMEN
The spatial structure of a neurokinin B molecule was investigated by the method of theoretical conformational analysis. The conformational analysis of this molecule indicated that the possible structure of neurokinin B under polar conditions may be described by five families of low-energy conformations possessing a conformationally relatively rigid C-terminal heptapeptide and variable N-terminal fragments.
Asunto(s)
Modelos Químicos , Neuroquinina A/química , Neuroquinina B/química , Animales , Humanos , Estructura Terciaria de ProteínaRESUMEN
The spatial structure of the neurokinin A molecule was studied by the method of theoretical conformational analysis. On the basis of fragmental analysis, stable structures of the neurokinin A molecule under polar conditions were determined. The structures can be described by four families of low-energy conformations having a relatively labile tripeptide at the C-end and a conformationally rigid heptapeptide at the N-end. It was shown that two of these conformations are virtually isoenergetic structures. One of these is an alpha-helical structure and the other forms two beta-turns at the N-terminus, which change to the turn of the alpha-helix at the C-end.
Asunto(s)
Neuroquinina A/química , Secuencia de Aminoácidos , Modelos Moleculares , Datos de Secuencia Molecular , Neuroquinina B/química , Conformación ProteicaRESUMEN
The Kell blood group is a highly polymorphic system containing over 20 different antigens borne by the protein Kell, a 93-kDa type II glycoprotein that displays high sequence homology with members of the M13 family of zinc-dependent metalloproteases whose prototypical member is neprilysin. Kell K1 is an antigen expressed in 9% of the Caucasian population, characterized by a point mutation (T193M) of the Kell K2 antigen, and located within a putative N-glycosylation consensus sequence. Recently, a recombinant, non-physiological, soluble form of Kell was shown to cleave Big ET-3 to produce the mature vasoconstrictive peptide. To better characterize the enzymatic activity of the Kell protein and the possible differences introduced by antigenic point mutations affecting post-translational processing, the membrane-bound forms of the Kell K1 and Kell K2 antigens were expressed either in K562 cells, an erythroid cell line, or in HEK293 cells, a non-erythroid system, and their pharmacological profiles and enzymatic specificities toward synthetic and natural peptides were evaluated. Results presented herein reveal that the two antigens possess considerable differences in their enzymatic activities, although not in their trafficking pattern. Indeed, although both antigens are expressed at the cell surface, Kell K1 protein is shown to be inactive, whereas the Kell K2 antigen binds neprilysin inhibitory compounds such as phosphoramidon and thiorphan with high affinity, cleaves the precursors of the endothelin peptides, and inactivates members of the tachykinin family with enzymatic properties resembling those of other members of the M13 family of metalloproteases to which it belongs.
Asunto(s)
Antígenos de Superficie/fisiología , Proteínas Sanguíneas/fisiología , Metaloproteasas/química , Antígenos/química , Antígenos de Superficie/química , Proteínas Sanguíneas/química , Células de la Médula Ósea/metabolismo , Brefeldino A/farmacología , Catálisis , Línea Celular , Membrana Celular/metabolismo , Separación Celular , Cromatografía Líquida de Alta Presión , Cartilla de ADN/química , ADN Complementario/metabolismo , Relación Dosis-Respuesta a Droga , Eritrocitos/metabolismo , Citometría de Flujo , Glicósido Hidrolasas/metabolismo , Glicosilación , Humanos , Hidrólisis , Células K562 , Cinética , Espectrometría de Masas , Metaloendopeptidasas/química , Microscopía Fluorescente , Neuroquinina A/química , Péptidos/química , Fenotipo , Reacción en Cadena de la Polimerasa , Espectrometría de Masa por Ionización de Electrospray , Especificidad por Sustrato , Taquicininas/química , Taquicininas/metabolismo , Temperatura , Transfección , Zinc/químicaRESUMEN
A functional fluorescent neurokinin NK2 receptor, EGFP-NK2, was previously used to follow, by fluorescence resonance energy transfer measurements in living cells, the binding of its fluorescently labeled agonist, bodipy-neurokinin A (NKA). Local agonist application suggested that the activation and desensitization of the NK2 receptors were compartmentalized at the level of the plasma membrane. In this study, fluorescence recovery after photobleaching experiments are carried out at variable observation radius (vrFRAP) to probe EGFP-NK2 receptor mobility and confinement. Experiments are carried out at 20 degrees C to maintain the number of receptors constant at the cell surface during recordings. In the absence of agonist, 35% EGFP-NK2 receptors diffuse within domains of 420 +/- 80 nm in radius with the remaining 65% of receptors able to diffuse with a long range lateral diffusion coefficient between the domains. When cells are incubated with a saturating concentration of NKA, 30% EGFP-NK2 receptors become immobilized in small domains characterized by a radius equal to 170 +/- 50 nm. Biochemical experiments show that the confinement of EGFP-NK2 receptor is not due to its association with rafts at any given time. Colocalization of the receptor with beta-arrestin and transferrin supports that the small domains, containing 30% of activated EGFP-NK2, correspond to clathrin-coated pre-pits. The similar amount of confined EGFP-NK2 receptors found before and after activation (30-35%) is discussed in term of putative transient interactions of the receptors with preexisting scaffolds of signaling molecules.
Asunto(s)
Membrana Celular/metabolismo , Receptores de Neuroquinina-2/química , Arrestinas/metabolismo , Compuestos de Boro/farmacología , Línea Celular , Clatrina/química , Difusión , Relación Dosis-Respuesta a Droga , Recuperación de Fluorescencia tras Fotoblanqueo , Colorantes Fluorescentes/farmacología , Vectores Genéticos , Proteínas Fluorescentes Verdes/química , Proteínas Fluorescentes Verdes/metabolismo , Humanos , Immunoblotting , Lípidos/química , Microscopía Confocal , Microscopía Fluorescente , Modelos Químicos , Neuroquinina A/química , Octoxinol/farmacología , Estructura Terciaria de Proteína , Receptores de Neuroquinina-2/metabolismo , Temperatura , Factores de Tiempo , Transfección , Transferrina/metabolismo , Xantenos/farmacología , beta-ArrestinasRESUMEN
Two tachykinin peptides, bufokinin and Xenopus neurokinin A (X-NKA) were recently isolated from Xenopus laevis. In this study we investigated the tachykinin receptors in the Xenopus gastrointestinal tract. In functional studies using stomach circular muscle strips, all peptides had similar potencies (EC50 values 1-7 nM). The rank order of potency to contract the intestine was physalaemin (EC50 1 nM)> or =bufokinin (EC50 3 nM)>substance P (SP)> or =cod SP>NKA>>X-NKA (EC50 1,900 nM). No maximum response could be obtained for [Sar9,Met(O2)11]SP, eledoisin and kassinin. In stomach strips, the mammalian tachykinin receptor antagonists RP 67580 (NK1) and MEN 10376 (NK2) had agonistic effects but did not antagonize bufokinin or X-NKA. In intestinal strips, RP 67580 (1 microM) reduced the maximal response to X-NKA but not bufokinin, while MEN 10376 was ineffective. [125I]BH-bufokinin bound with high affinity to a single class of sites, of KD 213+/-35 (stomach) and 172+/-9.3 pM (intestine). Specific binding of [125I]BH-bufokinin was displaced by bufokinin> or =SP>NKA> or =eledoisin approximately kassinin>X-NKA, indicating binding to a tachykinin NK1-like receptor. Selective tachykinin receptor antagonists were weak or ineffective. Other iodinated tachykinins ([125I]NKA and [125I]BH-eledoisin) displayed biphasic competition profiles, with the majority of sites preferring bufokinin rather than X-NKA. In conclusion, there is evidence for two different tachykinin receptors in Xenopus gastrointestinal tract. Both receptors may exist in stomach, whereas the bufokinin-preferring NK1-like receptor predominates in longitudinal muscle of the small intestine. Antagonists appear to interact differently with amphibian receptors, compared with mammalian receptors.
Asunto(s)
Neuroquinina A/análogos & derivados , Fisalemina/análogos & derivados , Receptores de Taquicininas/química , Receptores de Taquicininas/efectos de los fármacos , Especificidad de la Especie , Sustancia P/análogos & derivados , Xenopus/metabolismo , Animales , Sitios de Unión/efectos de los fármacos , Cardias/citología , Cardias/efectos de los fármacos , Cardias/metabolismo , Relación Dosis-Respuesta a Droga , Eledoisina/farmacología , Femenino , Indoles/farmacología , Péptidos y Proteínas de Señalización Intercelular/química , Péptidos y Proteínas de Señalización Intercelular/farmacología , Intestino Delgado/citología , Intestino Delgado/efectos de los fármacos , Intestino Delgado/metabolismo , Radioisótopos de Yodo , Isoindoles , Kasinina/farmacología , Masculino , Contracción Muscular/efectos de los fármacos , Contracción Muscular/fisiología , Músculo Liso/efectos de los fármacos , Músculo Liso/fisiología , Neuroquinina A/antagonistas & inhibidores , Neuroquinina A/química , Neuroquinina A/farmacología , Fragmentos de Péptidos/farmacología , Fisalemina/farmacología , Receptores de Taquicininas/fisiología , Sustancia P/farmacologíaRESUMEN
The solution structure of NKA, a decapeptide of mammalian origin, has been characterized by CD spectropolarimetry and 2D proton nuclear magnetic resonance (2D 1H-NMR) spectroscopy in both aqueous and membrane mimetic solvents. Unambiguous NMR assignments of protons have been made with the aid of correlation spectroscopy (DQF-COSY and TOCSY) experiments and nuclear Overhauser effect spectroscopy (NOESY and ROESY) experiments. The distance constraints obtained from the NMR data have been utilized to generate a family of structures, which have been refined using restrained energy minimization and dynamics. These data show that in water NKA prefers to be in an extended chain conformation whereas a helical conformation is induced in the central core and the C-terminal region (D4-M10) of the peptide in the presence of perdeuterated dodecylphosphocholine (DPC) micelles, a membrane model system. Though less defined the N-terminus also displays some degree of order and a possible turn structure. The conformation adopted by NKA in the presence of DPC micelles represents a structural motif typical of neurokinin-2 selective agonists and is similar to that reported for eledoisin in hydrophobic environment.
Asunto(s)
Micelas , Neuroquinina A/química , Fosforilcolina/análogos & derivados , Taquicininas/química , Algoritmos , Membrana Celular/metabolismo , Dicroismo Circular , Metabolismo de los Lípidos , Espectroscopía de Resonancia Magnética , Modelos Moleculares , Neuroquinina A/metabolismo , Fosforilcolina/química , Unión Proteica , Conformación Proteica , Estructura Secundaria de Proteína , Estructura Terciaria de Proteína , Protones , Receptores de Neuroquinina-2/químicaRESUMEN
Two peptides with limited structural similarity to mammalian substance P (SP) and neurokinin A (NKA) have been isolated from extracts of the intestine of the African clawed frog (Xenopus laevis). The primary structure of an SP-like peptide was established as: Lys-Pro-Arg-Pro-Asp-Gln-Phe-Tyr-Gly-Leu-Met.NH(2), which is identical to the previously characterized peptide, bufokinin isolated from the toad Bufo marinus. The primary structure of an NKA-related peptide was established as Thr-Leu-Thr-Thr-Gly-Lys-Asp-Phe-Val-Gly-Leu-Met.NH(2). Only the five amino acids at the C-terminal region of the peptide are identical to mammalian NKA whereas the N-terminal region shows no structural similarity to previously characterized tachykinins. Immunohistochemical investigations of the gut wall revealed a dense network of nerve fibres and nerve cell bodies containing SP/NKA-like substances. The myotropic effects of the Xenopus tachykinins were compared with the contractile effect of mammalian SP and NKA on isolated strips of circular smooth muscle from Xenopus stomach. No significant differences in potencies (-log EC(50)) or in intrinsic activities were observed between the Xenopus and mammalian peptides. The potencies for the Xenopus SP-like (8.49+/-0.15) and the NKA-like peptide (8.12+/-0.06) were similar suggesting that the amino acid sequence at the N-terminal region of the tachykinins is not important in activating the tachykinin receptors in Xenopus gastric smooth muscle. The maximum response to Xenopus SP (alpha=0.59+/-0.06) was significantly lower than to the NKA-like peptide (alpha=1.0) suggesting a more effective interaction of the NKA-like peptide with the tachykinin receptor(s) in Xenopus stomach.
Asunto(s)
Neuroquinina A/química , Sustancia P/química , Taquicininas/química , Taquicininas/aislamiento & purificación , Secuencia de Aminoácidos , Animales , Atropina/farmacología , Bufo marinus , Inmunohistoquímica , Intestinos/química , Intestinos/efectos de los fármacos , Intestinos/fisiología , Metisergida/farmacología , Músculo Liso/química , Músculo Liso/efectos de los fármacos , Músculo Liso/inervación , Fibras Nerviosas/ultraestructura , Neuroquinina A/análisis , Neuroquinina A/aislamiento & purificación , Homología de Secuencia de Aminoácido , Estómago/química , Estómago/efectos de los fármacos , Estómago/fisiología , Sustancia P/aislamiento & purificación , Taquicininas/análisis , Tetrodotoxina/farmacología , Xenopus laevisRESUMEN
A structure-activity study of the neurokinin A (NKA) fragment NKA(4-10) was performed to investigate the importance of amino acid residues for receptor efficacy, potency and affinity at the NK(2) receptor in human colon circular muscle. Fourteen analogs of NKA(4-10) were produced with substitutions at positions 4, 5, 7, 9 and/or 10 of NKA. Their potencies were determined by in vitro contractile responses and affinities by radioligand binding using [125I]NKA. Functional potency was enhanced 8-fold by single amino acid substitutions with Lys(5) and MeLeu(9) but not significantly altered by substitutions Glu(4), Arg(5), His(5) and Nle(10). The multiply-substituted analogs [MeLeu(9),Nle(10)]NKA(4-10), [Lys(5),MeLeu(9),Nle(10)]NKA(4-10) and [Lys(5),(Tyr(7)),MeLeu(9),Nle(10)]NKA(4-10) displayed 6-9-fold increase in potency. Although [Arg(5),Nle(10)]NKA(4-10) was similar in potency to NKA(4-10), it was the only analog to show significantly reduced efficacy. All analogs were able to compete fully for [125I]NKA binding. [Lys(5),MeLeu(9)]NKA(4-10), [MeLeu(9),Nle(10)]NKA(4-10), [Lys(5),Nle(10)]NKA(4-10) and analogs containing single substitutions with Glu(4), Arg(5), Lys(5) and MeLeu(9) displayed significantly higher affinity, whereas those with Nle(10) and [Glu(4),Nle(10)] substitutions showed significantly lower affinity than NKA(4-10). There was a positive correlation (r=0.63) between binding affinity and functional potency, which was markedly improved (r=0.95) by removal of three analogs: [Lys(5),MeLeu(9),Nle(10)]NKA(4-10), [Lys(5),Tyr(7),MeLeu(9),Nle(10)]NKA(4-10) and [Lys(5),Tyr(I(2))(7),MeLeu(9),Nle(10)]NKA(4-10). These exhibited similar binding affinities to that of NKA(4-10) but were more potent in functional studies, possibly indicating a different mechanism of receptor interaction. In conclusion, substitution of Ser(5) with Lys, and/or N-methylation of Leu(9), were the most effective changes to increase functional and binding potency of NKA(4-10) at the human colon NK(2) receptor.